The inhibition of TGF‐β1 activation by enhancing LAP may attenuate fibrosis, which has been demonstrated by a study showing that LAP and truncated LAP could alleviate liver fibrosis in vitro and in vivo via inhibition of TGF‐β/Smad signaling pathway.159. This evidence concerns the gene TGFB1 and Hepatic fibrosis.